Piramal Pharma Limited
Stock Forecast, Prediction & Price Target

Piramal Pharma Limited Financial Estimates

Piramal Pharma Limited Revenue Estimates

Piramal Pharma Limited EBITDA Estimates

Piramal Pharma Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
₹29.38B
 
N/A
₹30.95B
 
5.32%
₹81.71B
 
163.98%
Avg: ₹104.28B
Low: ₹104.28B
High: ₹104.28B
avg. 27.63%
Avg: ₹116.84B
Low: ₹116.84B
High: ₹116.84B
avg. 12.03%
Net Income
 
% change YoY
₹5.71B
 
N/A
₹3.75B
 
-34.21%
₹178.2M
 
-95.26%
Avg: ₹5.17B
Low: ₹4.09B
High: ₹5.47B
avg. 2805.86%
Avg: ₹9.52B
Low: ₹8.40B
High: ₹9.92B
avg. 83.89%
EBITDA
 
% change YoY
₹6.11B
 
N/A
₹4.10B
 
-32.91%
₹13.66B
 
233.24%
Avg: ₹16.03B
Low: ₹16.03B
High: ₹16.03B
avg. 17.33%
Avg: ₹17.96B
Low: ₹17.96B
High: ₹17.96B
avg. 12.03%
EPS
 
% change YoY
$4.68
 
N/A
$3.11
 
-33.54%
$0.14
 
-95.49%
Avg: $3.91
Low: $3.22
High: $4.3
avg. 2689.28%
Avg: $7.2
Low: $6.6
High: $7.8
avg. 84.37%
Operating Expenses
 
% change YoY
₹11.79B
 
N/A
₹12.78B
 
8.32%
₹48.47B
 
279.27%
Avg: ₹11.98B
Low: ₹11.98B
High: ₹11.98B
avg. -75.27%
Avg: ₹13.43B
Low: ₹13.43B
High: ₹13.43B
avg. 12.03%

FAQ

What is Piramal Pharma Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 1444.87% in 2026-2027.

We have gathered data from 4 analysts. Their low estimate is 4.09B, average is 5.17B and high is 5.47B.

What is Piramal Pharma Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 19.83% in 2026-2027.

We have gathered data from 5 analysts. Their low revenue estimate is ₹104.28B, average is ₹104.28B and high is ₹104.28B.

What is Piramal Pharma Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 1386.83% in 2026-2027.

We have gathered data from 4 analysts. Their low earnings per share estimate is $3.22, average is $3.91 and high is ₹4.3.